Cargando…
Neurotoxin Impurities: A Review of Threats to Efficacy
Recently launched esthetic botulinum toxin serotype A (BoNT/A) products include Nabota/Jeuveau, Meditoxin/Neuronox, and Botulax, which contain nontoxic accessory proteins and excipients. Clinical evidence supporting these formulations, including their purity and potential immunogenicity or their lin...
Autores principales: | Park, Je-Young, Sunga, Owen, Wanitphakdeedecha, Rungsima, Frevert, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015620/ https://www.ncbi.nlm.nih.gov/pubmed/32095419 http://dx.doi.org/10.1097/GOX.0000000000002627 |
Ejemplares similares
-
Comparison of botulinum neurotoxin type A formulations in Asia
por: Frevert, Jürgen, et al.
Publicado: (2018) -
Immunogenicity Associated with Aesthetic Botulinumtoxin A: A Survey of Asia-Pacific Physicians’ Experiences and Recommendations
por: Park, Je-Young, et al.
Publicado: (2022) -
Emerging Trends in Botulinum Neurotoxin A Resistance: An International Multidisciplinary Review and Consensus
por: Ho, Wilson W. S., et al.
Publicado: (2022) -
Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products
por: Frevert, Jürgen
Publicado: (2015) -
Content of Botulinum Neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®
por: Frevert, Jürgen
Publicado: (2012)